Man­u­fac­tur­ing roundup: Avid Bioser­vices ex­pands in Cal­i­for­nia; Charles Riv­er nets cell ther­a­py pro­duc­tion deal

A Cal­i­for­nia-based CD­MO will be look­ing to ex­pand its ca­pa­bil­i­ties in its home state to keep up with mar­ket de­mand.

Avid Bioser­vices is ex­pand­ing its lab­o­ra­to­ries in Tustin, Cal­i­for­nia around its ca­pac­i­ty for its mam­malian cell busi­ness.

The in­vest­ment is priced at $6 mil­lion, and the 4,500-square-foot ex­pan­sion is ex­pect­ed to be com­plet­ed by the end of the year. No out­side funds were nec­es­sary and the com­pa­ny used cash on hand to fund the project. This ex­pan­sion tails oth­er in­vest­ments the com­pa­ny has made to in­crease process de­vel­op­ment ca­pac­i­ty in 2019 and 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER